Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival
- PMID: 29776598
- PMCID: PMC6625665
- DOI: 10.1016/j.ygyno.2018.04.571
Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival
Abstract
Background: Standard surgical treatment for women with stage IB1 cervical cancer consists of radical hysterectomy. This study assesses survival outcomes of those treated with less radical surgery (LRS; conization, trachelectomy, simple hysterectomy) compared to more radical surgery (MRS; modified radical, radical hysterectomy).
Methods: Using the Surveillance, Epidemiology and End Results database, we identified women <45 years with FIGO stage IB1 cervical cancer diagnosed from 1/1998 to 12/2012. Only those who underwent lymph node (LN) assessment were analyzed. Disease-specific survivals (DSSs) of LRS were compared with those of MRS.
Results: Of 2571 patients, 807 underwent LRS and 1764 underwent MRS, all with LN assessment. For LRS vs. MRS, 28% vs. 23% were diagnosed with adenocarcinoma (p = 0.024), 31% vs. 39% had G3 disease (p < 0.001), 40% vs. 45% had tumor size >2 cm (p < 0.001), and 27% vs. 29% received adjuvant radiation therapy (p = 0.005). Median follow-up was 79 months (range, 0-179). Ten-year DSS for LRS vs. MRS was 93.5% vs. 92.3% (p = 0.511). There was no difference in 10-year DSS when stratified by tumor size ≤2 cm (LRS 95.1% vs. MRS 95.6%, p = 0.80) or > 2 cm (LRS 90.1% vs. MRS 88.2%, p = 0.48). Factors independently associated with increased risk of death included adenosquamous histology (HR 2.37), G3 disease (HR 2.86), tumors >2 cm (HR 1.82), and LN positivity (HR 2.42). Compared to MRS, LRS was not associated with a higher risk of death.
Conclusions: In a select group of young women with stage IB1 cervical cancer, LRS compared to MRS does not appear to compromise DSS.
Keywords: Cervical cancer; Conization; Disease-specific survival; Radical hysterectomy; Simple hysterectomy; Trachelectomy.
Copyright © 2018 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures

References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer Statistics CA Cancer J Clin 2011;61:69–90. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics 2017. CA Cancer J Clin. 2017;67:7–30. - PubMed
-
- Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. Epidemiol Biostat. 2001;6:7–43. - PubMed
-
- Panici PB, Cutillo G, Angioli R. Modulation of surgery in early invasive cervical cancer. Crit Rev Oncol Hematol. 2003;48:263–270. - PubMed
-
- Winter R, Haas J, Reich O, et al. Parametrial spread of cervical cancer in patients with negative pelvic lymph nodes. Gynecol Oncol. 2002;84:252–257. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical